Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.86%
1,100.75
-9.59
-0.86%
—1,110.341,110.371,117.241,097.84——
SIXC
Communications
SIXC
Communications
SIXC
-1.28%
612.57
-7.97
-1.28%
—620.54620.54622.67611.42——
SIXE
Energy
SIXE
Energy
SIXE
+1.42%
1,175.62
+16.42
+1.42%
—1,159.201,160.591,176.461,156.21——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.42%
1,728.58
-24.86
-1.42%
—1,753.441,749.081,762.011,724.74——
SIXM
Financials
SIXM
Financials
SIXM
-0.67%
644.46
-4.34
-0.67%
—648.80649.58655.73643.68——
SIXR
Staples
SIXR
Staples
SIXR
-0.60%
827.46
-5.03
-0.60%
—832.49832.07833.09826.15——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.74%
215.34
-3.82
-1.74%
—219.16219.16219.19214.93——
SIXT
Technology
SIXT
Technology
SIXT
-0.05%
3,111.81
-1.55
-0.05%
—3,113.363,120.793,143.643,105.16——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.64%
911.43
-15.24
-1.64%
—926.67927.99930.54910.08——
SIXV
Health care
SIXV
Health care
SIXV
-0.86%
1,476.84
-12.77
-0.86%
—1,489.611,499.051,499.051,475.10——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.75%
2,405.12
-18.14
-0.75%
—2,423.262,438.162,443.462,399.83——
BAYN:FRA
Bayer AG
€39.96
-3.31%
(-1.37) 1D
Apr 21, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BAYN...
Open
€41.36
High
€41.36
Low
€39.91
Mkt. cap
39.29B
Avg. vol.
9.32K
Volume
6.02K
Dividend
0.28%
Quarterly dividend
€0.03
Ex dividend date
Apr 27, 2026
52-wk high
€49.76
52-wk low
€20.53
EPS
-€3.68
Shares outstanding
932.55M
No. of employees
87K
News stories
From sources across the web
Profile
Bayer AG is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include pharmaceuticals, consumer healthcare products, agricultural chemicals, seeds and biotechnology products. The company is a component of the EURO STOXX 50 stock market index. Bayer was founded in 1863 in Barmen as a partnership between dye salesman Friedrich Bayer and dyer Johann Friedrich Weskott. The company was established as a dyestuffs producer, but the versatility of aniline chemistry led Bayer to expand its business into other areas. In 1899, Bayer launched the compound acetylsalicylic acid under the trademarked name Aspirin. Aspirin is on the World Health Organization's List of Essential Medicines. In 2021, it was the 34th most commonly prescribed medication in the United States, with more than 17 million prescriptions. In 1904, Bayer received a trademark for the "Bayer Cross" logo, which was, from 1910, subsequently stamped onto each aspirin tablet, creating an enduring brand image. Wikipedia
About Bayer AG
CEOBill Anderson
Employees87.3K
FoundedAug 1, 1863
Headquarters-
SectorPharmaceutical industry
Websitebayer.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
13.74B
10.74B
9.66B
11.44B
Cost of goods sold
5.62B
4.73B
4.31B
4.23B
Cost of revenue
5.62B
4.73B
4.31B
4.23B
Research and development expenses
1.46B
1.50B
1.50B
1.29B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.71B
3.77B
3.40B
5.37B
Operating expense
5.79B
5.02B
5.90B
3.89B
Total operating expenses
11.41B
9.74B
10.20B
8.12B
Operating income
2.32B
994.00M
-543.00M
3.32B
Other non operating income
-264.00M
-333.00M
-7.00M
1.51B
EBT including unusual items
1.83B
-426.00M
-1.16B
-3.37B
EBT excluding unusual items
1.83B
574.00M
-1.16B
4.63B
Income tax expense
526.00M
-236.00M
-202.00M
378.00M
Effective tax rate
28.74%
55.40%
17.40%
-11.21%
Other operating expenses
624.00M
-249.00M
993.00M
-2.76B
Net income
1.30B
-199.00M
-963.00M
-3.76B
Net profit margin
9.46%
-1.85%
-9.97%
-32.85%
Earnings per share
-
1.23
0.57
-
Interest and investment income
-
-
-
471.00M
Interest expense
-244.00M
-62.00M
-539.00M
-527.00M
Net interest expenses
-244.00M
-62.00M
-539.00M
-56.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
3.47B
1.35B
412.00M
4.72B
Gain or loss from assets sale
-15.00M
-230.00M
-33.00M
-191.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer